Ameritas Investment Partners, Inc. Solid Biosciences Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.43 - $1.24 $2,029 - $5,852	-4,720 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$3.49 - $5.51 $8,253 - $13,031	2,365 Added 100.42%	4,720 $17,000
Q4 2020 Feb 12, 2021	BUY	$3.08 - $7.79 $4,167 - $10,539	1,353 Added 135.03%	2,355 $18,000
Q3 2018 Nov 13, 2018	BUY	$36.35 - $51.7 $8,869 - $12,614	244 Added 32.19%	1,002 $47,000
Q2 2018 Aug 13, 2018	SELL	$7.33 - $43.15 $87 - $517	-12 Reduced 1.56%	758 $27,000
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $5,536 - $25,540	770 New	770 $6,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $52.4M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.